SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

StarkNet is a permissionless decentralized Layer 2 (L2) validity rollup, built to allow Ethereum to scale via cryptographic protocols called STARKs, without compromising Ethereum’s core principles of decentralization, transparency, inclusivity and security. The StarkNet Token is needed to operate the ecosystem, maintain and secure it, decide on its values and strategic goals, and direct its evolution. This token will be required for (i) governance, (ii) payment of transaction fees on StarkNet, and (iii) participation in StarkNet’s consensus mechanism.

Starknet

Starknet is trending due to its rapidly expanding ecosystem, evidenced by rising TVL, app revenue, and user growth, driven by its advanced ZK-STARK technology, increasing Bitcoin DeFi integrations, and ongoing focus on quantum resistance and privacy. The community widely discusses its robust long-term infrastructure build, viewing current valuations as a potential mispricing despite recent token unlock conversations.

Klarna Group Plc is a global digital bank and flexible payments provider. It operates through an AI-powered payments and commerce network that empowers people to pay smarter, with a mission to be available everywhere, for everything. The company was founded by Gustav Erik Niklas Adalberth, Karl Anders Victor Jacobsson, and Sebastian Marcin Siemiatkowski in 2005 and is headquartered in London, the United Kingdom.

Klarna Group plc

Klarna is trending due to its recent Q4 earnings report, which highlighted strong revenue growth and expanding user base but also a net loss and a softer Q1 outlook. This mixed performance has ignited a contentious debate among investors, who are weighing the company's "buy now, pay later" business model and profitability challenges against its market penetration and strategic partnerships.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL (GRAL) is highly debated after trial results for its multi-cancer early detection test missed a primary endpoint for statistically significant reduction in late-stage diagnoses. This has fueled a polarized discussion between those seeing an overreaction given the test's strong detection capabilities and ample cash runway, and others expressing significant concern for the company's future.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending following news of a public stock offering and a substantial royalty funding agreement, which the community is debating as either a necessary strategic capital raise to advance its oncology pipeline and meet financial obligations, or as a significant, ill-timed dilution impacting short-term share value.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - 8% PRF PERPETUAL USD 100 - Ser A

Strategy Inc 8.00% Series A Perpetual Strike Preferred Stock

Strategy Inc's 8.00% Series A Perpetual Strike Preferred Stock ($STRK) is a focal point of conversation, with investors debating its attractive dividend yield and direct correlation to MicroStrategy's Bitcoin acquisition strategy. However, the community also expresses notable concerns over potential dividend sustainability, dilution risks from new preferred offerings, and its value relative to other MicroStrategy preferred shares.

$SWEAT is the beating heart of the Movement Economy—a groundbreaking token that transforms physical activity into real-world value. Minted through movement, $SWEAT rewards your steps with a crypto asset that you can earn, trade, or grow. The team states that their app has increased their users’ physical activity by an average of 20%, creating a healthier society and reducing burdens on global healthcare systems. With over 20 million holders, SWEAT is eliminating barriers and making Web3 accessible to everyone, one step at a time.

Sweat Economy

Sweat Economy ($SWEAT) is trending due to significant community discussion surrounding its long-term potential, with many expressing hope for a future rebound despite its current low valuation and substantial price depreciation; users are actively highlighting its unique "move-to-earn" utility and staking opportunities.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver is trending following its strong Q4 earnings report, which highlighted record revenue, a significant profit turnaround, and impressive premiums from its direct-to-consumer silver sales. The community is overwhelmingly bullish, anticipating a major breakout driven by these robust fundamentals and broader tailwinds from increasing physical silver demand and a tightening COMEX supply.

Newmont Corp. engages in the exploration and acquisition of gold properties, containing copper, silver, lead, zinc or other metals. It operates through the following geographical segments: Canada, Mexico, Suriname, Argentina, Peru, Australia, Papua New Guinea, Ghana, and U.S. The company was founded by William Boyce Thompson on May 2, 1921 and is headquartered in Denver, CO.

Newmont Corp

Newmont is trending after reporting strong Q4 earnings and record free cash flow, though its mixed 2026 production and cost guidance has led to a 'sell the news' reaction. Despite the immediate dip, community discussion is vibrant with many viewing it as a buying opportunity, anticipating a continued parabolic rise for gold and the mining sector.

Venice boasts an innovative approach to generative AI with its unique privacy architecture, access to competitive features including multiple leading open-source LLM models such as DeepSeek R1, PDFs analysis, and image and code generation. An unrestricted AI Characters feature is available with its Pro version, Venice Pro.   VVV is designed to minimize friction and reduce costs for AI agents and developers to access private, reliable, on-demand and perpetual AI inference via Venice.ai's API.

Venice Token

Venice Token ($VVV) is trending amid significant token supply reductions, including burns and reduced emissions, alongside surging platform activity and strategic partnerships in the privacy-focused AI sector. The community is highly optimistic, discussing its unique uncensored AI offerings and low circulating supply as key drivers for substantial future growth.

Vanguard Group, Inc. - Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF

Vanguard Total Stock Market ETF ($VTI) is trending as market participants closely watch how broader economic conditions and political actions, particularly those linked to Donald Trump's policies, are influencing overall market sentiment, leading many in the community to discuss its role as a key barometer for U.S. stock performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Codexis (CDXS) Projected to Post Earnings on Thursday

Codexis (NASDAQ:CDXS) will be releasing its Q4 2025 earnings before the market opens on Thursday, February 26. (View Earnings Report at...

Incyte (INCY) Q4 Earnings Lag Estimates

Incyte (INCY) delivered earnings and revenue surprises of -7.06% and +12.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Telemark Asset Management LLC Increases Stock Position in Codexis, Inc. $CDXS

Telemark Asset Management LLC lifted its position in shares of Codexis, Inc. (NASDAQ:CDXS - Free Report) by 33.3% during the second quarter, according to its most recent disclosure with the...

Down 30% in 4 Weeks, Here's Why You Should You Buy the Dip in Codexis (CDXS)

Codexis (CDXS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Codexis (NASDAQ:CDXS) Rating Lowered to "Strong Sell" at Wall Street Zen

Wall Street Zen downgraded shares of Codexis from a "hold" rating to a "strong sell" rating in a research report on Saturday...

Codexis (NASDAQ:CDXS) Issues Quarterly Earnings Results, Misses Expectations By $0.07 EPS

Codexis (NASDAQ:CDXS - Get Free Report) issued its earnings results on Thursday. The biotechnology company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.15) by...

Codexis (CDXS) Reports Q3 Loss, Misses Revenue Estimates

Codexis (CDXS) delivered earnings and revenue surprises of -46.67% and -53.96%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates

EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -10.39% and -85.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates

Tarsus Pharmaceuticals (TARS) delivered earnings and revenue surprises of +14.29% and +2.80%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis Manufacturing Platform for Therapeutic siRNA Manufacturing

Codexis and Nitto Denko Avecia Enter Evaluation Agreement to Explore Codexis's ECO Synthesis Manufacturing Platform for Therapeutic siRNA Manufacturing Codexis and Nitto Denko Avecia Enter Evaluation...

Codexis, Inc. is an enzyme engineering company, which engages in the development and sale of therapeutics. It operates through the Performance Enzymes and Novel Biotherapeutics segments. The Performance Enzymes segment commercializes CodeEvolver protein engineering technology platform and products in the pharmaceuticals market. The Novel Biotherapeutics segment targets new opportunities to discover and improve biotherapeutic drug candidates. Its products include screening kits and Codex HiFi Hot Start DNA Polymerase. The company was founded in January 2002 and is headquartered in Redwood City, CA.

CDXS
Codexis Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CDXS News

CDXSCodexis Inc.